Clinical Trial Update: Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating α-RT for advanced castration-resistant prostate cancer with limited bone metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital Freiburg | Conditions: Prostate Carcinoma | Phase 2 | Status: UNKNOWN